MV
Madrona Venture Group, LLC
Concentrated strategyQuality / disciplined sizing
Total reported value
$22.1M
Reporting period: 2025-12-31 · Number of holdings: 3
Madrona Venture Group, LLC disclosed 3 holdings in its latest 13F filing for the period ending 2025-12-31, with total reported value of $22.1M and a quarterly turnover rate of 48.8%.
Personality snowflake
- Concentration
- 100
- Portfolio Stability
- 48.75
- Momentum/Contrarian
- 50
- Sector conviction
- 0
- Diversification
- 6
- Sizing Uniformity
- 91.67
Recent moves
Add NAUT
0.0% $6.7M
Trim PATH
0.0% $1.8M
Trim DNA
0.0% -$266.0K
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NAUT | Nautilus Biotechnology INC | Stock-Other | 53.24% | +16.48% | — | |
| 2 | PATH | Uipath INC - Class A | Stock-Tech | 45.16% | -13.60% | — | |
| 3 | DNA | Ginkgo Bioworks Holdings INC | Stock-Other | 1.60% | -2.87% | — |
Portfolio Performance
Not enough priced holdings yet to compute performance
Reported value over time
Sector allocation
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2025-12-31 | 3 | $22.1M | 49 | |
| 2025-09-30 | 3 | $13.8M | 100 | |
| 2025-06-30 | 3 | $12.6M | 0 | |
| 2025-03-31 | 3 | $28.5M | 0 | |
| 2024-12-31 | 4 | $53.8M | 0 | |
| 2024-09-30 | 4 | $74.6M | 0 | |
| 2024-06-30 | 4 | $93.7M | 0 | |
| 2024-03-31 | 4 | $117.5M | 0 | |
| 2023-12-31 | 6 | $427.1M | 0 | |
| 2023-09-30 | 6 | $291.9M | 0 | |
| 2023-06-30 | 5 | $274.6M | 0 | |
| 2023-03-31 | 6 | $246.7M | 0 | |
| 2022-12-31 | 5 | $207.5M | 0 | |
| 2022-09-30 | 5 | $217.3M | 0 | |
| 2022-06-30 | 5 | $215.4M | 0 | |
| 2022-03-31 | 5 | $337.7M | 0 | |
| 2021-12-31 | 4 | $529.4M | 0 | |
| 2021-09-30 | 4 | $752.3M | 0 | |
| 2021-06-30 | 3 | $617.4M | 0 | |
| 2021-03-31 | 2 | $544.4M | 0 | |
| 2020-12-31 | 2 | $741.5M | 0 |
Holding changes this quarter
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | NAUT | Nautilus Biotechnology INC | +16.5% | — | Unchanged |
| 2 | DNA | Ginkgo Bioworks Holdings INC | -2.9% | — | Unchanged |
| 3 | PATH | Uipath INC - Class A | -13.6% | — | Unchanged |
FAQ
What is Madrona Venture Group, LLC and what type of investor is it?
Madrona Venture Group, LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2025-12-31), the firm manages a tracked equity portfolio valued at approximately $22.1M, spread across 3 disclosed positions.
What are Madrona Venture Group, LLC's largest equity positions?
Based on the latest 13F filing, Madrona Venture Group, LLC's top holdings by market value are:
1. Nautilus Biotechnology INC (NAUT) — $11.7M (53.2%)
2. Uipath INC - Class A (PATH) — $10.0M (45.2%)
3. Ginkgo Bioworks Holdings INC (DNA) — $353.0K (1.6%)
What changes did Madrona Venture Group, LLC make in its most recent portfolio filing?
No notable portfolio changes were recorded for Madrona Venture Group, LLC in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Madrona Venture Group, LLC focus on?
Madrona Venture Group, LLC is concentrated in the following sectors based on its current disclosed equity portfolio:
• Information Technology: 100.0%